New combo attack on breast cancer: radiation & immune drug before chemo

NCT ID NCT07188246

Recruiting now Disease control Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Source: ClinicalTrials.gov ↗

Summary

This study is testing a new treatment approach for people with high-risk breast cancer. Before starting standard chemotherapy, participants receive a short, targeted course of radiation and two injections of an immunotherapy drug directly into the tumor. The goal is to 'prime' the immune system to better fight the cancer, potentially improving the effectiveness of the chemotherapy that follows.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St. Joseph's Health Care London
NOT_YET_RECRUITING

London, Ontario, N6A 4V2, Canada
St. Joseph's Health Care London
RECRUITING

London, Ontario, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BREAST CANCER BREAST CANCER INVASIVE BREAST CANCER STAGE II BREAST CANCER STAGE III BREAST CANCER TRIPLE NEGATIVE